June Sherie Almenoff
Director · Actinium Pharmaceuticals, Inc.
IndividualBuying only2 10b5-1 trades
- 2024
- Sep 4, 2026
- 6
Other insiders active in the same sector
No other insider has filed at June Sherie Almenoff's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
- Andrew J. Mills - $75.00M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is June Sherie Almenoff?
June Sherie Almenoff is a corporate insider, tracked as Director of Actinium Pharmaceuticals, Inc. (ATNM). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has June Sherie Almenoff submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has June Sherie Almenoff been buying or selling stock?
Recorded transactions: 4 open-market purchases ($28K) and 0 open-market sales across all tracked filings.
